Claudie Hooper , Emmanuel González , Nicola Coley , Bruno Vellas , Sophie Guyonnet , for the MAPT/IHU HealthAge Open Science group
{"title":"有记忆障碍的老年人血浆维生素D与血浆磷酸化tau-181和血浆神经丝轻链的横断面关联","authors":"Claudie Hooper , Emmanuel González , Nicola Coley , Bruno Vellas , Sophie Guyonnet , for the MAPT/IHU HealthAge Open Science group","doi":"10.1016/j.nbd.2025.107041","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lack of vitamin D is associated with cognitive decline and Alzheimer's disease. Therefore, we examined the relationship between plasma 25 hydroxyvitamin D [25(OH)D] and plasma phosphorylated-tau 181 (p-tau 181) and neurofilament light chain (NfL) in older adults with memory complaints.</div></div><div><h3>Methods</h3><div>This is a cross-sectional analysis of ‘Multidomain Alzheimer Preventive Trial’ baseline data. Subjects were 519 French community-dwelling adults aged 70<sup>+</sup> years at risk of dementia with baseline data on plasma 25(OH)D and plasma p-tau 181 and 311 individuals with baseline data on plasma 25(OH)D and plasma NfL. Plasma 25(OH)D, p-tau 181 and NfL were measured using high-sensitivity immune-based assays and associations were explored using adjusted regression analyses.</div></div><div><h3>Results</h3><div>Subjects had a mean (SD) age of 75.2 years (4.3) and 67.6 % were female. The mean (SD) plasma 25(OH)D concentration was 23.5 ng/ml (11.3). The mean (SD) concentrations of plasma p-tau 181 and plasma NfL were 9.9 pg/ml (4.5) and 81.1 pg/ml (34.1) respectively. We did not find significant cross-sectional associations between baseline plasma 25(OH)D and plasma p-tau 181 (Model 3: β-coefficient, 0.0003, 95 % CI: −0.0036, 0.0042, <em>p</em> = 0.879) or plasma 25(OH)D and plasma NfL (Model 3: β-coefficient, −0.0012, 95 % CI: −0.0055, 0.0032, <em>p</em> = 0.599). Age, cognitive status, sex, cardiovascular risk or <em>apolipoprotein</em> ε4 genotype did not modify these non-significant associations.</div></div><div><h3>Conclusions</h3><div>These findings provide evidence that plasma 25(OH)D is not associated with plasma p-tau 181 or plasma NfL in older adults with heightened dementia risk. Longitudinal replication studies are essential to validate these cross-sectional results.</div></div>","PeriodicalId":19097,"journal":{"name":"Neurobiology of Disease","volume":"214 ","pages":"Article 107041"},"PeriodicalIF":5.6000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cross-sectional associations of plasma vitamin D with plasma phosphorylated tau-181 and plasma neurofilament light chain in older adults with memory complaints\",\"authors\":\"Claudie Hooper , Emmanuel González , Nicola Coley , Bruno Vellas , Sophie Guyonnet , for the MAPT/IHU HealthAge Open Science group\",\"doi\":\"10.1016/j.nbd.2025.107041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Lack of vitamin D is associated with cognitive decline and Alzheimer's disease. Therefore, we examined the relationship between plasma 25 hydroxyvitamin D [25(OH)D] and plasma phosphorylated-tau 181 (p-tau 181) and neurofilament light chain (NfL) in older adults with memory complaints.</div></div><div><h3>Methods</h3><div>This is a cross-sectional analysis of ‘Multidomain Alzheimer Preventive Trial’ baseline data. Subjects were 519 French community-dwelling adults aged 70<sup>+</sup> years at risk of dementia with baseline data on plasma 25(OH)D and plasma p-tau 181 and 311 individuals with baseline data on plasma 25(OH)D and plasma NfL. Plasma 25(OH)D, p-tau 181 and NfL were measured using high-sensitivity immune-based assays and associations were explored using adjusted regression analyses.</div></div><div><h3>Results</h3><div>Subjects had a mean (SD) age of 75.2 years (4.3) and 67.6 % were female. The mean (SD) plasma 25(OH)D concentration was 23.5 ng/ml (11.3). The mean (SD) concentrations of plasma p-tau 181 and plasma NfL were 9.9 pg/ml (4.5) and 81.1 pg/ml (34.1) respectively. We did not find significant cross-sectional associations between baseline plasma 25(OH)D and plasma p-tau 181 (Model 3: β-coefficient, 0.0003, 95 % CI: −0.0036, 0.0042, <em>p</em> = 0.879) or plasma 25(OH)D and plasma NfL (Model 3: β-coefficient, −0.0012, 95 % CI: −0.0055, 0.0032, <em>p</em> = 0.599). Age, cognitive status, sex, cardiovascular risk or <em>apolipoprotein</em> ε4 genotype did not modify these non-significant associations.</div></div><div><h3>Conclusions</h3><div>These findings provide evidence that plasma 25(OH)D is not associated with plasma p-tau 181 or plasma NfL in older adults with heightened dementia risk. Longitudinal replication studies are essential to validate these cross-sectional results.</div></div>\",\"PeriodicalId\":19097,\"journal\":{\"name\":\"Neurobiology of Disease\",\"volume\":\"214 \",\"pages\":\"Article 107041\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurobiology of Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0969996125002578\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurobiology of Disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0969996125002578","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Cross-sectional associations of plasma vitamin D with plasma phosphorylated tau-181 and plasma neurofilament light chain in older adults with memory complaints
Background
Lack of vitamin D is associated with cognitive decline and Alzheimer's disease. Therefore, we examined the relationship between plasma 25 hydroxyvitamin D [25(OH)D] and plasma phosphorylated-tau 181 (p-tau 181) and neurofilament light chain (NfL) in older adults with memory complaints.
Methods
This is a cross-sectional analysis of ‘Multidomain Alzheimer Preventive Trial’ baseline data. Subjects were 519 French community-dwelling adults aged 70+ years at risk of dementia with baseline data on plasma 25(OH)D and plasma p-tau 181 and 311 individuals with baseline data on plasma 25(OH)D and plasma NfL. Plasma 25(OH)D, p-tau 181 and NfL were measured using high-sensitivity immune-based assays and associations were explored using adjusted regression analyses.
Results
Subjects had a mean (SD) age of 75.2 years (4.3) and 67.6 % were female. The mean (SD) plasma 25(OH)D concentration was 23.5 ng/ml (11.3). The mean (SD) concentrations of plasma p-tau 181 and plasma NfL were 9.9 pg/ml (4.5) and 81.1 pg/ml (34.1) respectively. We did not find significant cross-sectional associations between baseline plasma 25(OH)D and plasma p-tau 181 (Model 3: β-coefficient, 0.0003, 95 % CI: −0.0036, 0.0042, p = 0.879) or plasma 25(OH)D and plasma NfL (Model 3: β-coefficient, −0.0012, 95 % CI: −0.0055, 0.0032, p = 0.599). Age, cognitive status, sex, cardiovascular risk or apolipoprotein ε4 genotype did not modify these non-significant associations.
Conclusions
These findings provide evidence that plasma 25(OH)D is not associated with plasma p-tau 181 or plasma NfL in older adults with heightened dementia risk. Longitudinal replication studies are essential to validate these cross-sectional results.
期刊介绍:
Neurobiology of Disease is a major international journal at the interface between basic and clinical neuroscience. The journal provides a forum for the publication of top quality research papers on: molecular and cellular definitions of disease mechanisms, the neural systems and underpinning behavioral disorders, the genetics of inherited neurological and psychiatric diseases, nervous system aging, and findings relevant to the development of new therapies.